Raymond James Starts Neogenomics (NEO) at Outperform
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Raymond James initiated coverage on Neogenomics (NASDAQ: NEO) with an Outperform rating and a price target of $10.00.
Shares of Neogenomics closed at $8.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts MedEquities Realty Trust (MRT) at Outperform
- First Analysis Starts Inovalon Holdings (INOV) at Equal Weight
- UPDATE: Seaport Global Securities Starts Canadian Pacific Railway Limited (CP) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!